Angioedema in a Patient with Underlying Lymphoproliferative Disorder.

[1]  Chen Wang,et al.  Where we are with acquired angioedema due to C1 inhibitor deficiency: A systematic literature review. , 2021, Clinical immunology.

[2]  J. Bernstein,et al.  US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema. , 2020, The journal of allergy and clinical immunology. In practice.

[3]  J. Bernstein,et al.  Angioedema in the emergency department: a practical guide to differential diagnosis and management , 2017, International Journal of Emergency Medicine.

[4]  M. Scarpellini,et al.  Drug-induced angioedema: experience of Italian emergency departments , 2013, Internal and Emergency Medicine.

[5]  Henry E. Wang,et al.  National estimates of emergency department visits for angioedema and allergic reactions in the United States. , 2013, Allergy and asthma proceedings.

[6]  P. Keith,et al.  2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema , 2010, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

[7]  K. Kragballe,et al.  Hereditary Angioedema. , 2018, The New England journal of medicine.

[8]  Jennifer S. Kim,et al.  Hereditary and acquired angioedema. , 2019, Allergy and asthma proceedings.